Efficacy And Safety Of Antegrade Uretroscopic Lithotripsy Versus Retrograde Ureteroscopic Lithotripsy In The Treatment Of Upper Ureteric Stones Measuring > 10 mm In Maximum Dimension. A Randomized Comparative Study
mm millimeter
1 other identifier
interventional
100
1 country
1
Brief Summary
This study aims to assess the efficacy and safety of antegrade flexible ureteroscopic lithotripsy in treating upper ureteric stones \>10 mm in maximum dimension and impacted upper ureteric stones irrespective of size in comparison to retrograde ureteroscopic lithotripsy and evaluate feasibility, adverse events, hospital stay and cost benefit of both techniques
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 14, 2025
CompletedFirst Submitted
Initial submission to the registry
January 15, 2026
CompletedFirst Posted
Study publicly available on registry
January 23, 2026
CompletedJanuary 23, 2026
January 1, 2026
3.4 years
January 15, 2026
January 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
stone free rate
stone free rate was compared between the 2 arms
3 weeks after the intervention
Study Arms (2)
group A
ACTIVE COMPARATORAntegrade flexible ureteroscopy
group B
ACTIVE COMPARATORretrograde flexible ureteroscopy
Interventions
The antegrade approach with this stone size will further prove the superior stone free rate compared with the retrograde approach, widen the indication for the antegrade approach and prove the more favorable perioperative safety profile
he antegrade approach with this stone size will further prove the superior stone free rate compared with the retrograde approach, widen the indication for the antegrade approach and prove the more favorable perioperative safety profile
Eligibility Criteria
You may qualify if:
- patients with upper urteric stone larger than 10 mm in maximum diameter from the level of pelviureteric junction to upper border of sacroiliac junction and aged ≥18 years
You may not qualify if:
- unresolved urinary tract infection, uncorrected coagulopathy, pregnancy, anatomical abnormalities of the urinary system as horse shoe kidney, pelvic ectopic kidney and ureteric strictures, severe orthopedic malformation hindering prone position or antegrade ureteric access as kyphosis and scoliosis, Pediatric age groups \< 18 years, ureteric Stent in place, concurrent renal stones, bladder cancer, upper urothelial tumors or renal tumors
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University hospitals
Cairo, Cairo Governorate, Egypt
Related Publications (3)
Gokce MI, Akpinar C, Obaid K, Suer E, Gulpinar O, Beduk Y. Comparison of retrograde ureterorenoscopy (URS) and percutaneous anterograde ureteroscopy for removal of impacted upper ureteral stones >10mm in the elderly population. Int Braz J Urol. 2021 Jan-Feb;47(1):64-70. doi: 10.1590/S1677-5538.IBJU.2019.0638.
PMID: 32840338BACKGROUNDElgebaly O, Abdeldayem H, Idris F, Elrifai A, Fahmy A. Antegrade mini-percutaneous flexible ureteroscopy versus retrograde ureteroscopy for treating impacted proximal ureteric stones of 1-2 cm: A prospective randomised study. Arab J Urol. 2020 Aug 23;18(3):176-180. doi: 10.1080/2090598X.2020.1769385.
PMID: 33029428BACKGROUNDMohey A, Abdelfattah AA, Mohammed AE, Marzouk A, El-Dakhakhny AS. Comparative study between antegrade flexible ureteroscopy and reterograde intrarenal surgery in the management of impacted upper ureteric stones 1.5 cm or larger. World J Urol. 2023 Dec;41(12):3731-3736. doi: 10.1007/s00345-023-04672-w. Epub 2023 Nov 3.
PMID: 37921933BACKGROUND
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD candidate
Study Record Dates
First Submitted
January 15, 2026
First Posted
January 23, 2026
Study Start
March 15, 2022
Primary Completion
August 10, 2025
Study Completion
September 14, 2025
Last Updated
January 23, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- for 6 months after publication
- Access Criteria
- access for all requesting urologists via Email of central contact person
all IPD that underlie results in a publication